Cargando…

Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study

BACKGROUND: Circulating immune cells influence the efficacy of cancer therapy. This study aimed to investigate the prognostic values of different peripheral blood leukocyte (PBL) biomarkers in non-small lung cancer (NSCLC) patients treated with chemoradiotherapy. METHODS: An independent cohort of 17...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Min, Xu, Qinghua, Yang, Shuangyan, Han, Shuiyun, Zhu, Yaoyao, Lin, Qingren, Sun, Xiaojiang, Liu, Hui, Xu, Yaping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661896/ https://www.ncbi.nlm.nih.gov/pubmed/33209890 http://dx.doi.org/10.21037/atm-20-6484

Ejemplares similares

A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer
por: Jiang, Chenxue, et al.
Publicado: (2018)

A Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma
por: Sun, Xiaojiang, et al.
Publicado: (2016)

Pretreatment Inflammatory Indexes as Prognostic Predictors for Survival in Colorectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
por: Yang, Jing, et al.
Publicado: (2018)

Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer
por: Sun, Xiaojiang, et al.
Publicado: (2020)

Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients
por: Xu, Litao, et al.
Publicado: (2017)

Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer
por: Han, Shuiyun, et al.
Publicado: (2015)

Talking to Siri
por: Sadun, Erica, et al.
Publicado: (2012)

Siri for dummies
por: Saltzman, Marc
Publicado: (2013)

IDO1 Activity Predicts Lung Toxicity in Patients with Unresectable Stage III NSCLC and Chemoradiotherapy
por: Wu, Linfang, et al.
Publicado: (2023)

The Predictive Role of Systemic Inflammation Response Index (SIRI) in the Prognosis of Stroke Patients
por: Zhang, Yihui, et al.
Publicado: (2021)

Take Control of Siri
por: McFarland, Scholle
Publicado: (2019)

A Novel Prognostic Marker Systemic Inflammation Response Index (SIRI) for Operable Cervical Cancer Patients
por: Chao, Bei, et al.
Publicado: (2020)

Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapy
por: Wu, Linfang, et al.
Publicado: (2022)

Systemic Inflammation Response Index (SIRI) Independently Predicts Survival in Advanced Lung Adenocarcinoma Patients Treated with First-Generation EGFR-TKIs
por: Jiang, Shun, et al.
Publicado: (2021)

Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease
por: Liu, Yuanjun, et al.
Publicado: (2020)

iPad & Siri for dummies
por: Baig, Edward C
Publicado: (2012)

From Eliza to Siri and Beyond
por: Coheur, Luísa
Publicado: (2020)

Inflammation index SIRI is associated with increased all-cause and cardiovascular mortality among patients with hypertension
por: Zhao, Songfeng, et al.
Publicado: (2023)

The efficacy and safety of Zengxiao Jiandu decoction combined with definitive concurrent chemoradiotherapy for unresectable locally advanced non-small cell lung cancer: a randomized, double-blind, placebo-controlled clinical trial
por: Wu, Leilei, et al.
Publicado: (2022)

Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer
por: Bobbili, Priyanka, et al.
Publicado: (2020)

Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis
por: Lin, Qingren, et al.
Publicado: (2019)

The CT appearance pattern of radiation-induced lung injury and tumor recurrence after stereotactic body radiation therapy in early stage non-small cell lung cancer
por: Li, Qian, et al.
Publicado: (2020)

Use of the systemic inflammation response index (SIRI) as a novel prognostic marker for patients on peritoneal dialysis
por: Li, Jiaqi, et al.
Publicado: (2022)

Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study
por: Horinouchi, Hidehito, et al.
Publicado: (2020)

Radiosensitizing effect of c-Met kinase inhibitor BPI-9016M in esophageal squamous cell carcinoma cells in vitro and in vivo
por: Jiang, Chenxue, et al.
Publicado: (2021)

Exploring the Correlation Between the Systemic Immune Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), and Type 2 Diabetic Retinopathy
por: Wang, Shuqi, et al.
Publicado: (2023)

Using iPhone's Siri voice command
por: Miser, Brad
Publicado: (2012)

Language Impairments in Individuals With Coffin-Siris Syndrome
por: Vasko, Ashley, et al.
Publicado: (2022)

High PD-L1 expression is associated with a favorable prognosis in patients with esophageal squamous cell carcinoma undergoing postoperative adjuvant radiotherapy
por: Jiang, Chenxue, et al.
Publicado: (2019)

Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort
por: Qi, Wei‐Xiang, et al.
Publicado: (2023)

Concurrent sintilimab with sequential chemoradiotherapy for unresectable, stage III non-small cell lung cancer: a retrospective study
por: Tang, Shi, et al.
Publicado: (2023)

Pretreatment SUV(max) value to predict outcome in patients with stage III NSCLC receiving concurrent chemoradiotherapy
por: Yaprak, Gokhan, et al.
Publicado: (2019)

High preoperative CEA and systemic inflammation response index (C-SIRI) predict unfavorable survival of resectable colorectal cancer
por: Cai, Hao, et al.
Publicado: (2023)

Consolidation chwemotherapy after concurrent chemoradiotherapy vs. chemoradiotherapy alone for locally advanced unresectable stage III non-small-cell lung cancer: A meta-analysis
por: Chang, Xiu-Jun, et al.
Publicado: (2016)

Efficacy and cost‐effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059)
por: Ai, XinLei, et al.
Publicado: (2023)

A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
por: Gupta, Arunima, et al.
Publicado: (2014)

High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in China
por: Sun, Lejia, et al.
Publicado: (2020)

Chronic Urticaria Treatment with Omalizumab—Verification of NLR, PLR, SIRI and SII as Biomarkers and Predictors of Treatment Efficacy
por: Tarkowski, Bartłomiej, et al.
Publicado: (2023)

Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy
por: Xu, Cai, et al.
Publicado: (2019)

Talking to Siri: learning the language of Apple's intelligent assistant
por: Sadun, Erica, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1l2jivaacipeg1rqdspp1ltjge